Solvay Settles Estratest False Marketing Suit For $16M
Judge Richard Kyle of the U.S. District Court for the District of Minnesota signed off on the settlement Tuesday. Class members include people who purchased Solvay's Estratest or Estratest H.S. hormone replacement therapy drugs in the U.S., excluding California, since March 8, 1998.
To view the full article, register now.